ADORA2A and cancer: The correlation analysis of 24 immunosuppressants indicated that EDNRA was positively correlated with ADORA2A, CSF1R, KDR, TGFB1, and TGFBR1 in cancers, including BLCA, CHOL, ESCA, READ, and STAD (Figure 6C).